Table 2. Anthropometric measurements, blood pressure, fasting plasma glucose and serum lipids according to dietary oil intake.

Variable	Dietary oil intake, g/d			Ptrend-value
	< 25 (n = 485)	25–49 (n = 467)	≥ 50 (n = 234)
Data are presented as means ± SD or n (%).
Body mass index, kg/m2	24.3 ± 3.3	24.4 ± 3.1	24.8 ± 3.1	0.07
General obesity	64 (13.2%)	61 (13.1%)	31 (13.3%)	0.99
Waist circumference, cm	84.1 ± 15.9	84.9 ± 13.7	85.5 ± 15.9	0.22
Waist-to-hip ratio	0.89 ± 0.08	0.89 ± 0.06	0.90 ± 0.06	0.08
Central obesity	81 (16.7%)	72 (15.4%)	44 (18.8%)	0.63
Systolic blood pressure, mmHg	137.2 ± 18.4	136.6 ± 17.5	137.2 ± 17.0	0.88
Diastolic blood pressure, mmHg	78.0 ± 11.2	77.9 ± 10.2	77.0 ± 10.8	0.26
Use of antihypertensive drugs	208 (42.9%)	222 (47.5%)	127 (54.3%)	0.004
Fasting plasma glucose, mmol/L	5.92 ± 1.32	6.22 ± 1.89	6.33 ± 1.83	0.003
Use of antidiabetic drugs	45 (9.3%)	60 (12.9%)	24 (10.3%)	0.43
Serum triglycerides, mmol/L	1.64 ± 0.93	1.65 ± 1.12	1.59 ± 0.95	0.62
Serum total cholesterol, mmol/L	5.11 ± 1.13	5.02 ± 1.13	4.99 ± 1.08	0.22
Serum high-density lipoprotein cholesterol, mmol/L	1.51 ± 0.39	1.46 ± 0.39	1.49 ± 0.59	0.49
Serum low-density lipoprotein cholesterol, mmol/L	2.95 ± 0.91	2.94 ± 0.90	2.93 ± 0.87	0.76
Use of fibrates	0	1 (0.2%)	0	0.78
Use of statins	16 (3.3%)	21 (4.5%)	14 (6.0%)	0.09